Services: Diversified Services

Myriad Genetics Inc (MYGN: NASDAQ)

$36.96 -1.04 | -2.74%
10/24/14 - 04:00 PM ET
Company Profile
Price and Volume
Recent Price 38.00
52 Week High 42.50
52 Week Low 20.02
Avg. Daily Vol. (Mil) 0.78
Beta (3 year) 0.77
Share Related Items
Mkt Cap (Mil) 2,773.92
Shares Out (Mil) 72.80
Float (Mil) 45.09
Dividend Information
Yield % 0.00
Annual Dividend 0.00
Payout Ratio 0.00
Financial Strength
Quick Ratio 3.40
Current Ratio 4.00
LT Debt/ Equity 0.00
Total Debt / Equity 0.00
Valuation Ratios
Price Earnings 16.90
Price/Sales 3.55
Price/Book 3.85
Price/Cash Flow 14.60
Per Share Data
Earnings 2.25
Sales 10.69
Book Value 9.88
Cash Flow 2.61
Business Summary
Myriad Genetics Inc is a molecular diagnostic company. It develops and markets novel predictive medicine, personalized medicine and prognostic medicine tests. It also provides physicians with information to solve unmet medical needs.
General Information
320 Wakara Way
Salt Lake City, UT 84108
Industry : Diversified Services
Sector: Services
Employees: 1649
CEO: Mr. Peter D. Meldrum
Short Interest
Current Month (Mil) 34.10
Previous Month (Mil) 34.87
Short Interest Ratio (Days) 49.50
Management Effectiveness
Return on Equity 24.50
Return on Assets 21.40
Return on Investments 24.50
Gross Margin 87.70
EBIT Margin 35.70
Profit Margin 22.60

Portfolios with MYGN

Latest MYGN Headlines from TheStreet

More Financial News for MYGN

Press Releases for MYGN

See All Press Releases

Partner Headlines for MYGN

brokerage partners
connect with Stockpickr
Fan us on FaceBook
Follow us on Twitter